Literature DB >> 27018971

Urothelial Dysfunction and Chronic Inflammation in Diabetic Patients with Overactive Bladder.

Chung-Cheng Wang1,2, Hann-Chorng Kuo3.   

Abstract

OBJECTIVES: To investigate urothelial dysfunction, suburothelial inflammation, and muscarinic receptor expression in diabetic patients with overactive bladder (OAB).
METHODS: A total 19 patients with OAB and diabetes mellitus (DM), 14 OAB patients without DM, and 10 healthy control subjects were enrolled in the study. Immunofluorescence staining of E-cadherin, zonula occludens-1 (ZO-1), tryptase (mast cell activation), and apoptosis tests on the bladder urothelium and suburothelium were performed. Tissue muscarinic receptor M2, M3, and purinergic receptor P2X3 levels were measured by Western blotting. Video urodynamic studies were analyzed in relation to immunofluorescence and western blotting results.
RESULTS: The mean age of the controls, OAB patients without and with DM were comparable (62.9 ± 6.9, 58.4 ± 21.3, and 68.9 ± 11.3 years, respectively, P = 0.25). E-cadherin and mast cell expression in the bladder urothelium samples of the DM-OAB group and the OAB group without DM differed significantly from those of the control group (all P < 0.05). However, immunofluorescence analyses including E-cadherin, mast cells, apoptotic cell counts, and ZO-1 were comparable between OAB patients with and without DM. In addition, M3 muscarinic protein expression in the bladders of OAB patients with and without DM was significantly higher than that in the control subjects. The video urodynamic parameters did not correlate with the immunofluorescence data, M2 and M3 muscarinic receptor data, or P2X3 protein expression.
CONCLUSION: Urothelial dysfunction and chronic suburothelial inflammation may contribute to the pathogeneses of OAB. However, DM does not aggravate the severity of urothelial inflammation in OAB patients.
© 2016 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  diabetes; overactive bladder; urothelial dysfunction

Mesh:

Substances:

Year:  2016        PMID: 27018971     DOI: 10.1111/luts.12126

Source DB:  PubMed          Journal:  Low Urin Tract Symptoms        ISSN: 1757-5664            Impact factor:   1.592


  7 in total

1.  Detrusor contractility to parasympathetic mediators is differentially altered in the compensated and decompensated states of diabetic bladder dysfunction.

Authors:  Nicole S Klee; Robert S Moreland; Derek M Kendig
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-29

Review 2.  Potential role of oxidative stress in the pathogenesis of diabetic bladder dysfunction.

Authors:  Qi-Xiang Song; Yi Sun; Kangli Deng; Jin-Yi Mei; Christopher J Chermansky; Margot S Damaser
Journal:  Nat Rev Urol       Date:  2022-08-16       Impact factor: 16.430

3.  Proteomic Analysis of Urothelium of Rats with Detrusor Overactivity Induced by Bladder Outlet Obstruction.

Authors:  Edmond Changkyun Park; Jae Sung Lim; Seung Il Kim; Sang-Yeop Lee; Yu-Kyung Tak; Chi-Won Choi; Sungho Yun; Joohyun Park; Minji Lee; Hyo Kyun Chung; Koon Soon Kim; Yong Gil Na; Ju Hyun Shin; Gun-Hwa Kim
Journal:  Mol Cell Proteomics       Date:  2018-02-01       Impact factor: 5.911

4.  Diabetic bladder dysfunction is associated with bladder inflammation triggered through hyperglycemia, not polyuria.

Authors:  Brian M Inouye; Francis M Hughes; Huixia Jin; Robin Lütolf; Kunal C Potnis; Jonathan C Routh; Douglas C Rouse; Wen-Chi Foo; J Todd Purves
Journal:  Res Rep Urol       Date:  2018-11-16

5.  Platelet-to-Lymphocyte Ratio Predicts the Presence of Diabetic Neurogenic Bladder.

Authors:  Yiying Liu; Xin Wang; Linying Wang; Wenwen Chen; Wenyue Liu; Tingting Ye; Jing Hong; Hong Zhu; Feixia Shen
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-04       Impact factor: 3.168

6.  Lower Urinary Tract Symptoms Among Females with Rheumatoid Arthritis: A Prospective Cross-Sectional Study.

Authors:  Faris Abushamma; Narjis Nassar; Sulafa Omar Najjar; Sobhe Mahmoud Hijaze; Amer Koni; Sa'ed H Zyoud; Amir Aghbar; Rifat Hanbali; Hashim Hashim
Journal:  Int J Gen Med       Date:  2021-11-18

Review 7.  The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A.

Authors:  Chung-Cheng Wang; Yung-Hong Jiang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2020-03-16       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.